Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.DE Filed Acc 0001193125-26-092071

Chief Financial Officer gave up 2,091 shares (to pay taxes)

  • Chief Financial Officer acquired 6,267 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Harmon Seth · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Exercise or conversion : show line 1 in the form +6,267 9,881 D
2026-03-03 Shares withheld for taxes : show line 2 in the form −2,091 $29.32 $61,308 7,790 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-03-02 Grant or award : show line 3 in the form Stock Option (Right to Buy) +102,850 102,850 D
2026-03-02 Grant or award : show line 4 in the form Restricted Stock Units +20,550 20,550 D
2026-03-03 Exercise or conversion : show line 5 in the form Restricted Stock Units −6,267 18,801 D
Loading xslF345X05/ownership.xml…